Literature DB >> 3124165

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant.

P Willner1, A Towell, D Sampson, S Sophokleous, R Muscat.   

Abstract

Rats exposed chronically (5-9 weeks) to a variety of mild unpredictable stressors showed a reduced consumption of and preference for saccharin or sucrose solutions. Preference deficits took at least 2 weeks to develop and were maintained for more than 2 weeks after termination of the stress regime. Sucrose preference was unaffected by 1 week of treatment with the tricyclic antidepressant DMI but returned to normal after 2-4 weeks of DMI treatment. DMI did not alter sucrose preference in unstressed animals. No significant changes were seen in saline preference either during stress or following drug treatment. DMI reduced blood corticosterone and glucose levels, but stress did not significantly alter either measure. The results are discussed in terms of an animal model of endogenous depression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124165     DOI: 10.1007/bf00187257

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Biochemical and behavioral correlates of chronic stress: effects of tricyclic antidepressants.

Authors:  J S Soblosky; J B Thurmond
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

2.  Animal model of depression: effects of electroconvulsive shock therapy.

Authors:  R J Katz
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

3.  Endocrine control of psychomotor activity in the rat: effects of chronic dexamethasone upon general activity.

Authors:  R J Katz; B J Carroll
Journal:  Physiol Behav       Date:  1978-01

4.  Further analysis of the specificity of a novel animal model of depression--effects of an antihistaminic, antipsychotic and anxiolytic compound.

Authors:  R J Katz; M Sibel
Journal:  Pharmacol Biochem Behav       Date:  1982-06       Impact factor: 3.533

Review 5.  The validity of animal models of depression.

Authors:  P Willner
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Acute and chronic stress effects on open field activity in the rat: implications for a model of depression.

Authors:  R J Katz; K A Roth; B J Carroll
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

7.  Amphetamine and tranylcypromine in an animal model of depression: pharmacological specificity of the reversal effect.

Authors:  R J Katz; K A Roth; K Schmaltz
Journal:  Neurosci Biobehav Rev       Date:  1981       Impact factor: 8.989

8.  Effects of zometapine, a structurally novel antidepressant, in an animal model of depression.

Authors:  R J Katz
Journal:  Pharmacol Biochem Behav       Date:  1984-10       Impact factor: 3.533

9.  Stress and depression: a test of the buffering model of social support.

Authors:  C S Aneshensel; J D Stone
Journal:  Arch Gen Psychiatry       Date:  1982-12

10.  Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants.

Authors:  L Kokkinidis; R M Zacharko; P A Predy
Journal:  Pharmacol Biochem Behav       Date:  1980-09       Impact factor: 3.533

View more
  504 in total

1.  The effects of repeated social defeat on long-term depressive-like behavior and short-term histone modifications in the hippocampus in male Sprague-Dawley rats.

Authors:  Fiona Hollis; Hui Wang; David Dietz; Akash Gunjan; Mohamed Kabbaj
Journal:  Psychopharmacology (Berl)       Date:  2010-05-08       Impact factor: 4.530

2.  Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse.

Authors:  Akiko Shimamoto; Joseph F Debold; Elizabeth N Holly; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

3.  Enhanced aggressive behaviour in a mouse model of depression.

Authors:  C R Yang; Y Y Bai; C S Ruan; H F Zhou; D Liu; X F Wang; L J Shen; H Y Zheng; X F Zhou
Journal:  Neurotox Res       Date:  2014-11-04       Impact factor: 3.911

4.  Neurochemical, hormonal, and behavioral effects of chronic unpredictable stress in the rat.

Authors:  Brittney M Cox; Fares Alsawah; Peter C McNeill; Matthew P Galloway; Shane A Perrine
Journal:  Behav Brain Res       Date:  2011-01-28       Impact factor: 3.332

5.  Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.

Authors:  R Muscat; M Papp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

7.  Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

Authors:  J L Moreau; F Jenck; J R Martin; S Perrin; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

9.  Novel antidepressant effects of Paeonol alleviate neuronal injury with concomitant alterations in BDNF, Rac1 and RhoA levels in chronic unpredictable mild stress rats.

Authors:  Xiu-Ling Zhu; Jing-Jing Chen; Fei Han; Chuan Pan; Ting-Ting Zhuang; Ya-Fei Cai; Ya-Ping Lu
Journal:  Psychopharmacology (Berl)       Date:  2018-05-12       Impact factor: 4.530

10.  Behavioral responses in rats submitted to chronic administration of branched-chain amino acids.

Authors:  Giselli Scaini; Gabriela C Jeremias; Camila B Furlanetto; Diogo Dominguini; Clarissa M Comim; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  JIMD Rep       Date:  2013-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.